Quader Sabina ＱｕａｄｅｒＳａｂｉｎａ

… Alternative Names

QUADER Sabina カデールサビーナ

Less

Researcher Number	90749699
Other IDs	https://orcid.org/0000-0002-9616-7408
Affiliation (Current)	2025: 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 副主幹研究員
Affiliation (based on the past Project Information) *help	2023: 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 副主幹研究員 2021 – 2022: 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 主任研究員 2017 – 2018: 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 主任研究員 2016 – 2017: 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), 川崎市産業振興財団, 主任研究員
Review Section/Research Field	Principal Investigator Nanomaterials chemistry / Basic Section 90120:Biomaterials-related / Biomedical engineering/Biomaterial science and engineering Except Principal Investigator Basic Section 90120:Biomaterials-related / Basic Section 50010:Tumor biology-related
Keywords	Principal Investigator Glioblastoma / Glucose Transporter 1 / pH sensitive / Ligand / Epirubicin / Polymer Micelle / NanoMedicine / combination-therapy / anticancer / PIC micelle … More / aminoglycosides / RNA-binding / Nucleic Acid / cancer / Polyion Complex / Aminoglycoside / polymer / siRNA / PolyIionComplex / Neomycin … More Except Principal Investigator Medulloblastoma / pH-triggered / Chemo-immunotherapy / childhood cancers / chemo-immunotherapy / medulloblastoma / ICIs / Nanomedicine / 抗PD-1抗体 / 併用 / HYAL / MMP / 耐性克服 / がん間質 / ナノ治療薬 / リモデリング / 膵臓癌 / 腫瘍間質 / ECM分解 / がん間質再構築 / 膵臓がん / ゲムシタビン / 免疫チェックポイント阻害剤 / エピルビシンミセル Less

Nanomedicine-based Chemo-Immunotherapy for the Treatment of Pediatric Brain Cancer
- Principal Investigator
  
  劉学瑩
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 90120:Biomaterials-related
- Research Institution
  Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine
Developing Nanomedicine that targets cellular heterogeneity for Complete Glioblastoma RemissionPrincipal Investigator
- Principal Investigator
  
  Quader Sabina
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 90120:Biomaterials-related
- Research Institution
  Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine
Development of nano-therapeutic agents to overcome immune checkpoint inhibitor resistance due to tumor stroma of intractable cancer
- Principal Investigator
  
  KINOH HIROAKI
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine
細胞内標的化スマートナノＤＤＳを用いた効率的かつ安全ながんワクチンの開発Principal Investigator
- Principal Investigator
  
  Quader Sabina
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for JSPS Fellows
- Research Field
  
  Nanomaterials chemistry
- Research Institution
  Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine
Exploiting Neomycin-RNA complexation to create PIC micelle based efficient transportation for therapeutic siRNAPrincipal Investigator
- Principal Investigator
  
  Quader Sabina
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Biomedical engineering/Biomaterial science and engineering
- Research Institution
  Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine

All 2023 2022 2021 2019 2018 2017

All Journal Article Presentation Patent

[Journal Article] Effective treatment of drug resistant recurrent breast tumors harboring cancer stem-like cells by staurosporine/epirubicin co-loaded polymeric micelles2017
- Author(s)
  J. Zhang, H. Kinoh, L. Hespel, X. Liu, S. Quader, J. Martin, T. Chida, H. Cabral, K. Kataoka,
- Journal Title
  
  Journal of Controlled Release, "Vol. 264, pp. 127-1335, 2017
  
  Volume: 264 Pages: 127-135
- DOI
  10.1016/j.jconrel.2017.08.025
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07234, KAKENHI-PROJECT-16H03179, KAKENHI-PROJECT-16F16731, KAKENHI-PROJECT-16K12904
[Journal Article] Proteasome inhibitor loaded micelles enhance antitumor activity through macrophage reprograming by NF-κB inhibition"2017
- Author(s)
  Hailiang Wu, Anqi Tao, John D. Martin, Sabina Quader, Xueying Liu, Kei Takahashi, Louise Hespel, Yutaka Miura, Yoshihiro Hayakawa, Tatsuro Irimura, Horacio Cabral, Kazunori Kataoka
- Journal Title
  
  J. Pharm. Sci,
  
  Volume: - Issue: 9 Pages: 30217-30224
- DOI
  10.1016/j.xphs.2017.03.031
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H03179, KAKENHI-PROJECT-16F16731, KAKENHI-PROJECT-25293011, KAKENHI-PROJECT-16H05422, KAKENHI-PROJECT-26670023, KAKENHI-PROJECT-16K12904
[Journal Article] Nanomaterial-Enabled Cancer Therapy2017
- Author(s)
  Sabina Quader, Kazunori Kataoka
- Journal Title
  
  Molecular Therapy
  
  Volume: 25 Issue: 7 Pages: 1501-1513
- DOI
  10.1016/j.ymthe.2017.04.026
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K12904
[Journal Article] cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors2017
- Author(s)
  S. Quader, X. Liu, Y. Chen, P. Mi, T. Chida, T. Ishii, Y. Miura, N. Nishiyama, H. Cabral, K. Kataoka
- Journal Title
  
  J. Control. Release
  
  Volume: 258 Pages: 56-66
- DOI
  10.1016/j.jconrel.2017.04.033
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04635, KAKENHI-PROJECT-16H03179, KAKENHI-PROJECT-16F16058, KAKENHI-PROJECT-16F16407, KAKENHI-PROJECT-16K15104, KAKENHI-PROJECT-16K12904
[Patent] 脳腫瘍治療薬2019
- Inventor(s)
  喜納,片岡,SQuader,持田,劉,ARMaity,福島
- Industrial Property Rights Holder
  川崎市産業振興財団
- Industrial Property Rights Type
  特許
- Filing Date
  2019
- Overseas
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Chemo-immunotherapy of nanomedicine and ICI for reprogramming tumor microenvironment to overcome ICI-resistance.2023
- Author(s)
  H. Kinoh, H. Cabral, X. Liu, S. Quader, K. Kataoka,
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02774
[Presentation] Polymeric Nanomedicine targets brain cancer.2023
- Author(s)
  S. Quader, X. Liu, H. Kinoh, H. Cabral, K. Kataoka
- Organizer
  The 13th SPSJ International Polymer Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02774
[Presentation] Chemo-Immunotherapy of Epirubicin micelle and anti-PD-1 antibody for Reprogramming Tumor Microenvironment to Overcome anti-PD-1 antibody-Resistance.2023
- Author(s)
  H. Kinoh, H. Cabral, X. Liu, S. Quader, K. Kataoka
- Organizer
  7th JCA-AACR Special Joint Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02774
[Presentation] Chemo-immunotherapy of nanomedicine and ICI for reprogramming tumor microenvironment to overcome ICI-resistance2023
- Author(s)
  H. Kinoh, H. Cabral, X. Liu, S. Quader, K. Kataoka
- Organizer
  The 14th Annual World Cancer Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02774
[Presentation] Stromal disruption of Nanomedicine overcome Immunocheck point inhibitor＆Drug resistance in Stroma-rich pancreatic cancer2022
- Author(s)
  H. Kinoh, H. Cabral, S. Quader, K. Kataoka
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02774
[Presentation] 悪性脳腫瘍（グリオブラストーマ）に対する免疫チェックポイント阻害剤の効果を飛躍的に高めるナノDDSを用いた化学免疫療法2021
- Author(s)
  H. Kinoh, H. Cabral, S. Quader, K. Kataoka
- Organizer
  第80回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02774
[Presentation] Delivering positively charged anticancer peptide drug using crosslinked and pH responsive nanomedicine2019
- Author(s)
  Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
- Organizer
  Sixth International Conference on Multifunctional, Hybrid and Nanomaterials
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Delivering positively charged peptide/drug using crosslinked and pH responsive nanomachine2018
- Author(s)
  Amit Ranjan Maity,Sabina Quader,Shigehito Osawa,Kazunori Kataoka
- Organizer
  67th The Society of Polymer Science of Japan (SPSJ) Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Targeting cancer using stimuli-sensitive polymeric micelle2018
- Author(s)
  Sabina Quader, Kazunori Kataoka
- Organizer
  International Symposium on Biorelated Polymers: 255th ACS National Meeting.
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K12904
[Presentation] Delivering Melittin using Crosslinked and pH responsive Nanomedicine2018
- Author(s)
  Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
- Organizer
  IPC 2018, The 12th SPSJ International Polymer Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Nanomachine to deliver positively charged anticancer peptidic drug using crosslinked and pH responsive platform2018
- Author(s)
  Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
- Organizer
  The 77th Annual Meeting of Japanese Cancer Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Nanomedicine to Target Glioblastoma2018
- Author(s)
  Sabina Quader, Xueying Liu, Horacio Cabral, Yu-Lin Su, Amit Ranjan Maity, Hiroaki Kinoh, Kazunori Kataoka
- Organizer
  The 77th Annual Meeting of Japanese Cancer Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Tuning the Drug Release Kinetics of pH-responsive Polymer Micelle to achieve better therapy outcome in Glioblastoma model.2018
- Author(s)
  Sabina Quader, Xueying Liu, Hiraoki Kinoh, Kazunori Kataoka
- Organizer
  67th SPSJ Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K12904
[Presentation] Delivering positively charged peptide/drug using crosslinked and pH responsive micelles2018
- Author(s)
  Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
- Organizer
  67th SPSJ annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17035
[Presentation] Nanocarrier system for cancer therapy2017
- Author(s)
  Sabina Quader
- Organizer
  Summer School Nanosciences, Fundamental and Applications Emphasizing in Nanomedicine. Institute of Technology Bandung, Indonesia.
- Invited
- Data Source
  KAKENHI-PROJECT-16K12904
[Presentation] Safe and effective transport of anti-cancer drug, thru pH-sensitive polymeric micelle.2017
- Author(s)
  Sabina Quader, Xueying Liu, Horacio Cabral, Kazunori Kataoka
- Organizer
  66th SPSJ Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K12904

1. KINOH HIROAKI (70283067)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
2. 劉学瑩 (30777470)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
3. 藤加珠子 (90342732)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. Cabral Horacio (10533911)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
5. MAITY AMIT

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
6. 青木伊知男

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 西山伸宏

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Quader Sabina Ｑｕａｄｅｒ Ｓａｂｉｎａ

QUADER Sabina カデール サビーナ

Research Projects

Research Products

Co-Researchers

Nanomedicine-based Chemo-Immunotherapy for the Treatment of Pediatric Brain Cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Developing Nanomedicine that targets cellular heterogeneity for Complete Glioblastoma RemissionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of nano-therapeutic agents to overcome immune checkpoint inhibitor resistance due to tumor stroma of intractable cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

細胞内標的化スマートナノＤＤＳを用いた効率的かつ安全ながんワクチンの開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Exploiting Neomycin-RNA complexation to create PIC micelle based efficient transportation for therapeutic siRNAPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Effective treatment of drug resistant recurrent breast tumors harboring cancer stem-like cells by staurosporine/epirubicin co-loaded polymeric micelles2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Proteasome inhibitor loaded micelles enhance antitumor activity through macrophage reprograming by NF-κB inhibition"2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Nanomaterial-Enabled Cancer Therapy2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors2017

Author(s)

Journal Title

DOI

Data Source

[Patent] 脳腫瘍治療薬2019

Inventor(s)

Industrial Property Rights Holder

Industrial Property Rights Type

Filing Date

Data Source

[Presentation] Chemo-immunotherapy of nanomedicine and ICI for reprogramming tumor microenvironment to overcome ICI-resistance.2023

Author(s)

Organizer

Data Source

[Presentation] Polymeric Nanomedicine targets brain cancer.2023

Author(s)

Organizer

Data Source

[Presentation] Chemo-Immunotherapy of Epirubicin micelle and anti-PD-1 antibody for Reprogramming Tumor Microenvironment to Overcome anti-PD-1 antibody-Resistance.2023

Author(s)

Organizer

Data Source

[Presentation] Chemo-immunotherapy of nanomedicine and ICI for reprogramming tumor microenvironment to overcome ICI-resistance2023

Author(s)

Organizer

Data Source

[Presentation] Stromal disruption of Nanomedicine overcome Immunocheck point inhibitor＆Drug resistance in Stroma-rich pancreatic cancer2022

Author(s)

Organizer

Quader Sabina ＱｕａｄｅｒＳａｂｉｎａ

QUADER Sabina カデールサビーナ